26+ Pieris Anticalin
Gif. Both alliances aim to tap pieris' anticalin platform technology, which engineers proteins to mimic the targeting and binding capabilities of antibodies, but in a smaller package. They are not structurally related to antibodies, which makes them a type of antibody mimetic.
Form 8 K Pieris Pharmaceuticals For Dec 07 from www.streetinsider.com
Chemicals and biochemicals used in. We have registered trademarks for pieris® and anticalin®. Pieris ag application date :
The company develops anticalin proteins that are low.
They are not structurally related to antibodies, which makes them a type of antibody mimetic. While of course this adds cash runway to bridge. Pieris ag is an independent biotechnology company advancing its proprietary anticalin(r) technology to create safer, more. Pieris ag application date :
